Journal article
Lipoprotein-associated phospholipase A2: A new therapeutic target
Abstract
Lipoprotein-associated phospholipase A2 is an enzyme produced by inflammatory cells, which binds to apolipoprotein B-containing lipoproteins and degrades oxidatively modified phospholipids in low-density lipoprotein cholesterol particles, leading to formation of proinflammatory and cytotoxic products. Experimental studies suggest a role for lipoprotein-associated phospholipase A2 in the formation of advanced rupture-prone atherosclerotic …
Authors
Lonn E
Journal
Canadian Journal of Cardiology, Vol. 26, , pp. 27a–31a
Publisher
Elsevier
Publication Date
March 2010
DOI
10.1016/s0828-282x(10)71058-8
ISSN
0828-282X